Charles Garrison Fathman

Company: Stanford School of Medicine

Job title: Professor of Medicine

Seminars:

Revitalizing Treg Function in Autoimmunity: An Innovative Protein Drug Conjugate Platform 11:30 am

IL-2Rx has developed a platform of IL-2 fusion protein-based therapeutics known as Protein Drug Conjugates (PDC) designed to restore Treg function in autoimmunity These PDCs carry detachable small molecule neddylation activating enzyme inhibitors, that restore or enhance autoimmune Treg functionRead more

day: Day One AM Non-Cell Based Approaches